
Merit Medical Systems MMSI
$ 86.76
-1.57%
Quarterly report 2025-Q2
added 07-30-2025
Country |
|
IPO year |
- |
Industry |
Medical instruments |
Stock Exchange |
NASDAQ GLOBALSPB |
Shares |
58.2 M |
Market Cap[1] |
$ 5.05 B |
EBITDA (LTM) |
$ 272 M |
P/E (LTM) |
40.81 |
P/S (LTM) |
3.62 |
EPS (LTM) |
2.16 |
Other stocks of industry "Medical instruments"
| Issuer | Price | % 24h | Market Cap | Exchange | Country | |
|---|---|---|---|---|---|---|
|
Atrion Corporation
ATRI
|
- | - | $ 810 M | Nasdaq Global Select Market,SPB | ||
|
Baxter International
BAX
|
$ 19.45 | 1.81 % | $ 9.92 B | NYSE,SPB | ||
|
Becton, Dickinson and Company
BDX
|
$ 194.43 | 0.19 % | $ 55.9 B | NYSE,SPB | ||
|
Luminex Corporation
LMNX
|
- | - | $ 1.75 B | Nasdaq Global Select Market | ||
|
Ekso Bionics Holdings
EKSO
|
$ 7.87 | -8.96 % | $ 159 M | Nasdaq Capital Market | ||
|
Akers Biosciences, Inc.
AKER
|
- | -9.52 % | $ 20.6 M | Nasdaq Capital Market | ||
|
Antares Pharma, Inc.
ATRS
|
- | - | $ 955 M | Nasdaq Capital Market | ||
|
Cantel Medical Corp.
CMD
|
- | -1.18 % | $ 3.4 B | NYSE | ||
|
CRH Medical Corporation
CRHM
|
- | - | $ 282 M | NYSE American | ||
|
Hill-Rom Holdings, Inc.
HRC
|
- | -0.05 % | $ 10.3 B | NYSE,SPB | ||
|
Harvard Bioscience
HBIO
|
$ 0.66 | -1.84 % | $ 28 M | Nasdaq Global Market | ||
|
Varian Medical Systems, Inc.
VAR
|
- | -0.02 % | $ 16.3 B | NYSE | ||
|
Repro Med Systems
KRMD
|
$ 5.53 | -4.91 % | $ 252 M | Nasdaq Capital Market | ||
|
Alcon
ALC
|
$ 77.03 | -2.26 % | $ 40.4 B | NYSE | ||
|
AtriCure
ATRC
|
$ 38.9 | -1.67 % | $ 1.83 B | Nasdaq Global Market,SPB | ||
|
ICU Medical
ICUI
|
$ 139.88 | -1.96 % | $ 3.41 B | Nasdaq Global Select Market,SPB | ||
|
electroCore
ECOR
|
$ 4.51 | 0.67 % | $ 24.9 K | Nasdaq Global Select Market | ||
|
iRhythm Technologies
IRTC
|
$ 175.47 | -1.11 % | $ 5.47 B | Nasdaq Global Select Market,SPB | ||
|
AngioDynamics
ANGO
|
$ 12.62 | -1.75 % | $ 516 M | Nasdaq Global Select Market | ||
|
Isoray
ISR
|
- | 0.03 % | $ 108 M | NYSE American | ||
|
The Cooper Companies
COO
|
$ 81.01 | -1.16 % | $ 16.1 B | NYSE,SPB | ||
|
Nephros
NEPH
|
$ 4.86 | -0.41 % | $ 50.5 M | Nasdaq Global Select Market | ||
|
Glaukos Corporation
GKOS
|
$ 111.1 | -1.6 % | $ 5.38 B | NYSE,SPB | ||
|
LeMaitre Vascular
LMAT
|
$ 80.3 | -0.99 % | $ 1.8 B | Nasdaq Global Market,SPB | ||
|
Haemonetics Corporation
HAE
|
$ 79.5 | -0.82 % | $ 4 B | NYSE,SPB | ||
|
InfuSystem Holdings
INFU
|
$ 8.54 | -4.74 % | $ 176 M | NYSE American | ||
|
Masimo Corporation
MASI
|
$ 127.63 | -1.87 % | $ 6.8 B | Nasdaq Global Select Market,SPB | ||
|
Intuitive Surgical
ISRG
|
$ 557.29 | -1.6 % | $ 198 B | Nasdaq Global Select Market,SPB | ||
|
OraSure Technologies
OSUR
|
$ 2.42 | 0.21 % | $ 180 M | Nasdaq Global Select Market,SPB | ||
|
Microbot Medical
MBOT
|
$ 2.06 | 2.75 % | $ 21 M | Nasdaq Global Select Market | ||
|
Milestone Scientific
MLSS
|
$ 0.29 | 6.19 % | $ 23.1 M | NYSE American | ||
|
NeuroMetrix
NURO
|
- | 5.05 % | $ 9.02 M | Nasdaq Global Select Market | ||
|
STERIS plc
STE
|
$ 249.69 | -1.52 % | $ 24.6 B | NYSE,SPB | ||
|
Envista Holdings Corporation
NVST
|
$ 21.64 | -0.35 % | $ 3.73 B | NYSE | ||
|
Stereotaxis
STXS
|
$ 2.28 | -0.87 % | $ 184 M | NYSE American | ||
|
Pro-Dex
PDEX
|
$ 37.65 | -2.16 % | $ 124 M | Nasdaq Global Select Market | ||
|
Predictive Oncology
POAI
|
- | - | $ 32.4 M | Nasdaq Capital Market | ||
|
Pulse Biosciences
PLSE
|
$ 13.27 | -3.39 % | $ 637 M | Nasdaq Global Select Market | ||
|
Utah Medical Products
UTMD
|
$ 56.34 | 0.68 % | $ 204 M | Nasdaq Global Select Market | ||
|
ResMed
RMD
|
$ 243.27 | 1.0 % | $ 35.5 B | NYSE,SPB | ||
|
DENTSPLY SIRONA
XRAY
|
$ 11.35 | -0.7 % | $ 2.31 B | Nasdaq Global Select Market,SPB | ||
|
Repligen Corporation
RGEN
|
$ 163.8 | -0.04 % | $ 9.13 M | Nasdaq Global Select Market,SPB | ||
|
BioLife Solutions
BLFS
|
$ 23.74 | -1.82 % | $ 1.09 B | Nasdaq Global Select Market | ||
|
Retractable Technologies
RVP
|
$ 0.76 | 0.97 % | $ 22.8 M | NYSE American | ||
|
STAAR Surgical Company
STAA
|
$ 23.36 | 1.17 % | $ 1.15 B | Nasdaq Global Market,SPB | ||
|
Teleflex Incorporated
TFX
|
$ 121.85 | -0.19 % | $ 5.71 B | NYSE,SPB | ||
|
West Pharmaceutical Services
WST
|
$ 274.42 | -0.29 % | $ 20 B | NYSE,SPB |
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.